1 |
Hasan SS, Ballou S, Keefer L, Vasant DH. Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a "smart" solution? Neurogastroenterol Motil 2023;35:e14554. [PMID: 36847206 DOI: 10.1111/nmo.14554] [Reference Citation Analysis]
|
2 |
Vlieger AM, Assa A, Borrelli O, Broekaert I, Deganello Saccomani M, Dolinsek J, Carpi de JM, Mas E, Miele E, Thomson M, Tzivinikos C, Benninga MA; Gastroenterology Committee of ESPGHAN. Hypnotherapy in Pediatric Gastroenterology. J Pediatr Gastroenterol Nutr 2023;76:9-13. [PMID: 36103277 DOI: 10.1097/MPG.0000000000003617] [Reference Citation Analysis]
|
3 |
Császár-Nagy N, Bókkon I. Hypnotherapy and IBS: Implicit, long-term stress memory in the ENS? Heliyon 2023;9:e12751. [PMID: 36685398 DOI: 10.1016/j.heliyon.2022.e12751] [Reference Citation Analysis]
|
4 |
Noble H, Hasan SS, Simpson V, Whorwell PJ, Vasant DH. Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice. BMJ Open Gastroenterol 2022;9:e001039. [DOI: 10.1136/bmjgast-2022-001039] [Reference Citation Analysis]
|
5 |
Hojo M, Nagahara A. Current perspectives on irritable bowel syndrome: a narrative review. J Int Med Res 2022;50:3000605221126370. [PMID: 36171718 DOI: 10.1177/03000605221126370] [Reference Citation Analysis]
|
6 |
Sasegbon A, Hasan SS, Whorwell PJ, Vasant DH. Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome. JGH Open. [DOI: 10.1002/jgh3.12770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Noble H, Hasan SS, Whorwell PJ, Vasant DH. The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic. Neurogastroenterol Motil 2022;34:e14347. [PMID: 35238428 DOI: 10.1111/nmo.14347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
8 |
Donnet AS, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol 2022;15:17562848221074208. [PMID: 35198040 DOI: 10.1177/17562848221074208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
9 |
Gillan C. Review article: the effectiveness of group and self-help hypnotherapy for irritable bowel syndrome and the implications for improving patients' choice and access to treatment. Aliment Pharmacol Ther 2021;54:1389-404. [PMID: 34591988 DOI: 10.1111/apt.16623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|